Koers Eastgate Biotech Corp. Other OTC
Aandelen
ETBI
US2772531008
Farmaceutische producten
Omzet 2015 | 0,13 0,12 | Omzet 2016 | - | Marktkapitalisatie | 9,82 mln. 9,03 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | -4 mln. -3,68 mln. | Nettowinst (verlies) 2016 | -2 mln. -1,84 mln. | EV/omzet 2015 | 52.069.161 x |
Nettoschuld 2015 | 1,35 mln. 1,24 mln. | Nettoschuld 2016 | 1,72 mln. 1,58 mln. | EV/omzet 2016 | - |
K/w-verhouding 2015 |
-0,85
x | K/w-verhouding 2016 |
-3,28
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 15-01-15 |
William Abajian
PSD | President | 66 | 01-06-16 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 12-04-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 22-05-12 |
Rose Perri
CEO | Chief Executive Officer | 55 | 15-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,09% | 693 mld. | |
+29,39% | 584 mld. | |
-1,34% | 372 mld. | |
+20,34% | 332 mld. | |
+7,39% | 294 mld. | |
+14,25% | 239 mld. | |
-3,03% | 211 mld. | |
+10,02% | 210 mld. | |
+8,49% | 168 mld. |